Decoy Therapeutics

Decoy Therapeutics (DecoyTx) is a pharmaceutical company commercializing its IMPACT platform, which designs and develops antiviral products that prevent viral infection. Decoy’s platform is fast (weeks to develop lead candidates), versatile (can use different payloads for different viruses/variants), and cheap (at scale, ~$1 USD/dose). DecoyTx is validating this platform with its first product, DCOY101, an immediate acting SARS-CoV-2 prophylactic nasal spray. This product prevents COVID-19 infection and transmission in high-risk vaccinated and unvaccinated patients.